Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma

The introduction of targeted therapies like the tyrosine kinase (TKI) and mammalian target of rapamycin (mTOR) inhibitors has improved patients´ survival in general. Nevertheless the prognosis remains limited. Therapies with a new mode of action are urgently warranted, especially those who would pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedke, Jens, Kruck, Stephan, Gakis, Georgios, Stenzl, Arnulf, Goebell, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514323/
https://www.ncbi.nlm.nih.gov/pubmed/25912622
http://dx.doi.org/10.1080/21645515.2015.1016657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514323/
https://www.ncbi.nlm.nih.gov/pubmed/25912622
http://dx.doi.org/10.1080/21645515.2015.1016657

Ejemplares similares